Nature Medicine, Published online: 01 October 2026; doi:10.1038/s41591-026-04674-2
A randomized trial in individuals with type 2 diabetes probed the kidney-protective mechanisms of semaglutide using a range of techniques, including histology, multiparametric MRI and transcriptomics.
